Officer and Director Transactions - AC Immune SA

On June 11, 2026, Roy Ervin Twyman, a director at AC Immune SA, was granted 16,568 restricted share units under the company's 2016 Stock Option and Incentive Plan (SOIP). Additionally, on the same date, Twyman received share options for 38,889 shares, also under the SOIP, with these options scheduled to fully vest on June 10, 2027. The filing also notes that the reported shares include 66,556 common shares underlying outstanding restricted share units. The reported transactions are marked as direct ownership.